KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Regeneron Pharmaceuticals (REGN) Tax Rate (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Tax Rate for 16 consecutive years, with 12.51% as the latest value for Q1 2026.

  • For Q1 2026, Tax Rate rose 187.0% year-over-year to 12.51%; the TTM value through Mar 2026 reached 14.22%, up 449.0%, while the annual FY2025 figure was 13.88%, 619.0% up from the prior year.
  • Tax Rate hit 12.51% in Q1 2026 for Regeneron Pharmaceuticals, down from 19.08% in the prior quarter.
  • Across five years, Tax Rate topped out at 19.08% in Q4 2025 and bottomed at 3.04% in Q1 2024.
  • Average Tax Rate over 5 years is 9.23%, with a median of 10.21% recorded in 2024.
  • Year-over-year, Tax Rate tumbled -1068bps in 2023 and then soared 1486bps in 2025.
  • Regeneron Pharmaceuticals' Tax Rate stood at 9.63% in 2022, then crashed by -111bps to 1.05% in 2023, then surged by 503bps to 4.22% in 2024, then soared by 352bps to 19.08% in 2025, then tumbled by -34bps to 12.51% in 2026.
  • According to Business Quant data, Tax Rate over the past three periods came in at 12.51%, 19.08%, and 17.2% for Q1 2026, Q4 2025, and Q3 2025 respectively.